EXHIBIT 99.3

                    AMERIMMUNE PHARMACEUTICALS, INC.

                       CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
              SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Amerimmune
Pharmaceuticals, Inc. (the "Company") on Form 10-Q for the period ended
June 30, 2002, as filed with the Securities and Exchange Commission on
the date hereof (the "Report"), I, Kenneth Collins, the Chief Financial
Officer of  the Company, certify, pursuant to 18 U.S.C. Subsection 1350,
as adopted pursuant to Subsection 906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge:

     (1)  The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
the Company.



                                   /s/ KENNETH COLLINS
                                   ---------------------------
                                   Kenneth Collins
                                   Chief Financial Officer
                                   August 13, 2002